Fast Track Your End-to-End LNP Development, Entering into Gene Therapy to Vaccination
& Beyond with Safety & IP Confidence for Accelerated Approval
If you are interested in the 2025 event, please get in touch at info@hansonwade.com
Delivering the Therapeutic Potential of LNPs at Your Flagship LNP Platform
The ever-growing community of LNP pioneers as tackled the challenges associated with developing safe, compliant and efficacious LNPs. Starting with the in vitro discovery of LNPs through to the manufacturing processes, with end-to-end synergy fundamental.
Industry powerhouses including Pfizer, Moderna and Alnylam came together alongside new companies to share their insights to this community such as Capstan Therapeutics, AbbVie, Mana Bio, Serina Therapeutics, Karma Biotechnologies and more.
With an expanded content offering a 4-track and 4-day summit format, we continue to be the most comprehensive, premium LNP content available to industry.
Leading Companies Attending Included:
60+
Expert Speakers
250+
Industry Leaders
10+
Roundtables & Discussions
10+
Hours of Dedicated Networking
Your World-Class Speaker Faculty Included:
Muthiah Manoharan
Senior Vice President - Innovation Chemistry & Alnylam Distinguished Scientist
Alnylam Pharmaceuticals
Muthiah Manoharan
Senior Vice President - Innovation Chemistry & Alnylam Distinguished Scientist
Alnylam Pharmaceuticals
What Was On?
More than just a meeting...
It has been fantastic to see our community grow over the years and continue to advance the development of LNPs.
In addition to the unrivalled scientific content in the form of presentations, panels and roundtable discussions, there was a variety of extra experiences allowing for maximum ROI out of your time at the conference.
4-Track Conference
The flagship summit returns and with it it brings back it's famed end-to-end conference programme full of unrivalled scientific content in the form of presentations, panels and roundtable discussions. This year, benefit from 4 parallel tracks of content to provide for all members of the team.
New! LNP 101 Day
Looking at expanding into the LNP space? We have the meeting for you! Take a look at our new-for-2024 Pre-Conference LNP 101 Day, taking place before the main conference programme kicks off to give you and your team a solid foundation for leveraging LNPs as a powerful delivery vehicle.
4-Track Workshop Day
Join our Pre-Conference Workshop Day to get a deep dive into key challenges within the space across Discovery & Screening, Formulation & Delivery, Characterization & Analytical Development and Process Development & Manufacturing.
New! IP Patenting & Commercial Partnerships Day
With a volatile LNP landscape and litigation more rife in the industry than ever, don't miss this unique chance to enhance your understanding of the intellectual property landscape in the LNP field, gaining clarity on collaborative practices while ensuring compliance with legal boundaries.
Poster Session
Interested in hearing what your peers are up to, or even sharing research of your own? Then don't miss our poster session sharing the latest innovations as part of the main conference programme with no extra charge.
Networking Opportunities
Nothing says LNP Formulation & Process Development Summit like dedicated networking opportunities! Take part in drinks receptions, speed networking opportunities, lunch briefings and more with 400+ biopharma experts dedicated to progressing LNPs.
2024 Lead Partner:
"Hearing from state-of-the-art scientists and technologies at the front tier of LNPs production, shelf-lie and targeting approaches."
Dan Peer, Vice President for Research & Development,Tel Aviv University
"Lipid Nanoparticles and mRNA therapeutics have entered an exciting stage of development and public awareness.
Bringing together key experts from various stages of discovery, scale-up and manufacturing is important to help spread knowledge and aid further development and utilization of this versatile drug modality"
Michael Munson, Senior Research Scientist, AstraZeneca